Simply Wall St.67d agoneutral
TEZSPIRE’s Positive EoE Phase 3 Results Could Be A Game Changer For Amgen (AMGN)Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
109last 24h
3127last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Barchart69d agoneutral
How Is Amgen’s Stock Performance Compared to Other General Drug ManufacturersInvestor's Business Daily69d agobearish
One Of Amgen's Biggest Moneymakers Cuts The Risk Of Dying By 20%Motley Fool71d agobullish
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?Simply Wall St.73d agoneutral
AstraZeneca (LSE:AZN) Reports Positive TEZSPIRE Phase 3 Results, Is The Discount Too Wide?Investor's Business Daily73d agoneutral
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?Clinical Trials Arena73d agoneutral
Amgen-AstraZeneca’s Tezspire nets another Phase III inflammatory disease winSimply Wall St.74d agobullish
Why Is Amgen (AMGN) Ending Its Crohn's Disease Research Partnership?